Difference between revisions of "Part:BBa K5322002"
Line 2: | Line 2: | ||
<partinfo>BBa_K5322002 short</partinfo> | <partinfo>BBa_K5322002 short</partinfo> | ||
− | |||
<html> | <html> | ||
Line 11: | Line 10: | ||
==Usage and Biology== | ==Usage and Biology== | ||
<p> | <p> | ||
− | + | The plasmid pET29a-J23119-RBS-Mfp5-T7 utilizes the pET29a vector for high-level expression in ,<i>Escherichia coli</i>. This system is controlled by the strong constitutive promoter J23119, which regulates the expression of the mussel foot protein Mfp5. The ribosome binding site (RBS) ensures efficient translation of the mRNA, while the T7 terminator provides a clean and efficient termination for transcription. This system is designed for the effective expression of Mfp5 under conditions not influenced by environmental factors, allowing it to exhibit its adhesive properties. | |
</P> | </P> | ||
Line 17: | Line 16: | ||
<html> | <html> | ||
<p> | <p> | ||
− | + | To express eukaryotic proteins in prokaryotic systems, we chose <i>Escherichia coli</i> BL21(DE3) as the chassis cell, using the strong promoter J23119 as the regulatory element for efficient expression of the adhesive protein. As shown in Figure 2-1, we designed the plasmid pET29a-J23119-RBS-Mfp5-T7. The plasmid was transferred to BL21(DE3) via homologous recombination, and single colonies of <i>E. coli</i> were selected on several transformation plates for plasmid extraction. We performed PCR verification using specific primers targeting a 512 bp fragment, as illustrated in Figure 2-2. Plasmids with correctly positioned bands were sequenced, and the sequencing results in Figure 2-3 confirmed the successful construction of the plasmid pET29a-J23119-RBS-Mfp5-T7. | |
</p> | </p> | ||
Line 26: | Line 25: | ||
</style> | </style> | ||
<div class="center-img"> | <div class="center-img"> | ||
− | <img src="https://static.igem.wiki/teams/5322/wet-lab/ | + | <img src="https://static.igem.wiki/teams/5322/wet-lab/21-pet29a-j23119-rbs-mfp5-t7.png" alt="pET29a-J23119-RBS-Mfp5-T7" width="300"> |
− | <p align="center"><b>Figure 2-1</b> Plasmid | + | <p align="center"><b>Figure 2-1</b> Plasmid pET29a-J23119-RBS-Mfp5-T7</p> |
</div> | </div> | ||
<div class="center-img"> | <div class="center-img"> | ||
− | <img src="https://static.igem.wiki/teams/ | + | <img src="https://static.igem.wiki/teams/5322/wet-lab/94-pcr-mfp5.png" alt="gel" width="500"> |
− | <p align="center"><b>Figure 2-2</b> Colony PCR gel electrophoresis of plasmid | + | <p align="center"><b>Figure 2-2</b> Colony PCR gel electrophoresis of plasmid pET29a-J23119-RBS-Mfp5-T7(512bp)</p> |
</div> | </div> | ||
<div class="center-img"> | <div class="center-img"> | ||
− | <img src="https://static.igem.wiki/teams/ | + | <img src="https://static.igem.wiki/teams/5322/wet-lab/95-cexu-5.png" alt="cexu" width="600"> |
− | <p align="center"><b>Figure 2-3</b> plasmid | + | <p align="center"><b>Figure 2-3</b> Sequencing results of plasmid pET29a-J23119-RBS-Mfp5-T7</p> |
</div> | </div> | ||
Line 45: | Line 44: | ||
<html> | <html> | ||
We verified the performance of the lysis module through dry experiments and plan to complete wet experimental validation of its lytic function in the future. Through literature review and numerical modeling validation, we found that after inducing the expression of antimicrobial peptides and lysis proteins with NO for twenty minutes, the engineered strain will be lysed by the lysis protein and release the antimicrobial peptides. Mathematical modeling confirmed that at this time, the concentration of antimicrobial peptides is sufficient to reach an effective inhibitory concentration. | We verified the performance of the lysis module through dry experiments and plan to complete wet experimental validation of its lytic function in the future. Through literature review and numerical modeling validation, we found that after inducing the expression of antimicrobial peptides and lysis proteins with NO for twenty minutes, the engineered strain will be lysed by the lysis protein and release the antimicrobial peptides. Mathematical modeling confirmed that at this time, the concentration of antimicrobial peptides is sufficient to reach an effective inhibitory concentration. | ||
+ | <style> | ||
+ | .center-img { | ||
+ | text-align:center; | ||
+ | } | ||
+ | </style> | ||
+ | <div class="center-img"> | ||
+ | <img src="https://https://static.igem.wiki/teams/5322/wet-lab/29-sds-mfp1.png" alt="SDS-PAGE" width="300"> | ||
+ | <p align="center"><b>Figure 3-1</b> Tricine-SDS-PAGE analysis of Mfp5</p> | ||
+ | </div> | ||
+ | |||
+ | <div class="center-img"> | ||
+ | <img src="https://static.igem.wiki/teams/5322/wet-lab/31-wb-mfp1.png" alt="WB" width="300"> | ||
+ | <p align="center"><b>Figure 3-2</b> Western Blot analysis of Mfp5</p> | ||
+ | </div> | ||
+ | |||
</html> | </html> | ||
==Sequence and Features== | ==Sequence and Features== | ||
− | <partinfo> | + | <partinfo>BBa_K53222002 SequenceAndFeatures</partinfo> |
<!-- Uncomment this to enable Functional Parameter display | <!-- Uncomment this to enable Functional Parameter display | ||
==Functional Parameters== | ==Functional Parameters== | ||
− | <partinfo> | + | <partinfo>BBa_K5322002 parameters</partinfo> |
<!-- --> | <!-- --> |
Revision as of 13:48, 30 September 2024
Constitutive Mfp5 Expression System
Contents
Usage and Biology
The plasmid pET29a-J23119-RBS-Mfp5-T7 utilizes the pET29a vector for high-level expression in ,Escherichia coli. This system is controlled by the strong constitutive promoter J23119, which regulates the expression of the mussel foot protein Mfp5. The ribosome binding site (RBS) ensures efficient translation of the mRNA, while the T7 terminator provides a clean and efficient termination for transcription. This system is designed for the effective expression of Mfp5 under conditions not influenced by environmental factors, allowing it to exhibit its adhesive properties.
Construction of the plasmid
To express eukaryotic proteins in prokaryotic systems, we chose Escherichia coli BL21(DE3) as the chassis cell, using the strong promoter J23119 as the regulatory element for efficient expression of the adhesive protein. As shown in Figure 2-1, we designed the plasmid pET29a-J23119-RBS-Mfp5-T7. The plasmid was transferred to BL21(DE3) via homologous recombination, and single colonies of E. coli were selected on several transformation plates for plasmid extraction. We performed PCR verification using specific primers targeting a 512 bp fragment, as illustrated in Figure 2-2. Plasmids with correctly positioned bands were sequenced, and the sequencing results in Figure 2-3 confirmed the successful construction of the plasmid pET29a-J23119-RBS-Mfp5-T7.
Figure 2-1 Plasmid pET29a-J23119-RBS-Mfp5-T7
Figure 2-2 Colony PCR gel electrophoresis of plasmid pET29a-J23119-RBS-Mfp5-T7(512bp)
Figure 2-3 Sequencing results of plasmid pET29a-J23119-RBS-Mfp5-T7
Protein Expression Validation
We verified the performance of the lysis module through dry experiments and plan to complete wet experimental validation of its lytic function in the future. Through literature review and numerical modeling validation, we found that after inducing the expression of antimicrobial peptides and lysis proteins with NO for twenty minutes, the engineered strain will be lysed by the lysis protein and release the antimicrobial peptides. Mathematical modeling confirmed that at this time, the concentration of antimicrobial peptides is sufficient to reach an effective inhibitory concentration.
Figure 3-1 Tricine-SDS-PAGE analysis of Mfp5
Figure 3-2 Western Blot analysis of Mfp5
Sequence and Features
No part name specified with partinfo tag.